Genetic factors of non-obstructive azoospermia: consequences on patients' and offspring health

C Krausz, F Cioppi - Journal of Clinical Medicine, 2021 - mdpi.com
Non-Obstructive Azoospermia (NOA) affects about 1% of men in the general population and
is characterized by clinical heterogeneity implying the involvement of several different …

Genetic intersection of male infertility and cancer

L Nagirnaja, KI Aston, DF Conrad - Fertility and sterility, 2018 - Elsevier
Recent epidemiological studies have identified an association between male factor infertility
and increased cancer risk, however, the underlying etiology for the shared risk has not been …

Germline sequencing analysis to inform clinical gene panel testing for aggressive prostate cancer

BF Darst, E Saunders, T Dadaev, X Sheng… - JAMA …, 2023 - jamanetwork.com
Importance Germline gene panel testing is recommended for men with advanced prostate
cancer (PCa) or a family history of cancer. While evidence is limited for some genes …

Germline sequencing DNA repair genes in 5545 men with aggressive and nonaggressive prostate cancer

BF Darst, T Dadaev, E Saunders… - JNCI: Journal of the …, 2021 - academic.oup.com
Background There is an urgent need to identify factors specifically associated with
aggressive prostate cancer (PCa) risk. We investigated whether rare pathogenic, likely …

[HTML][HTML] Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.

FC Hamdy, JL Donovan, JA Lane… - Health Technology …, 2020 - ncbi.nlm.nih.gov
BACKGROUND Prostate cancer is the most common cancer among men in the UK. Prostate-
specific antigen testing followed by biopsy leads to overdetection, overtreatment as well as …

DNA damage response in prostate cancer

MJ Schiewer, KE Knudsen - Cold Spring …, 2019 - perspectivesinmedicine.cshlp.org
Prostatic adenocarcinoma (PCa) remains a significant health concern. Although localized
PCa can be effectively treated, disseminated disease remains uniformly fatal. PCa is reliant …

A novel RNA aptamer identifies plasma membrane ATP synthase beta subunit as an early marker and therapeutic target in aggressive cancer

S Speransky, P Serafini, J Caroli, S Bicciato… - Breast cancer research …, 2019 - Springer
Purpose Primary breast and prostate cancers can be cured, but metastatic disease cannot.
Identifying cell factors that predict metastatic potential could guide both prognosis and …

[HTML][HTML] Next generation mapping reveals novel large genomic rearrangements in prostate cancer

W Jaratlerdsiri, EKF Chan, DC Petersen, C Yang… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Complex genomic rearrangements are common molecular events driving prostate
carcinogenesis. Clinical significance, however, has yet to be fully elucidated. Detecting the …

Patient-level DNA damage repair pathway profiles and anti-tumor immunity for gastric cancer

S Lou, Y Wang, J Zhang, X Yin, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
DNA damage repair (DDR) comprises the detection and correction of alterations in the
chemical structure of DNA. The dysfunction of the DDR process has been determined to …

Genome-wide association study (GWAS) of circulating vitamin D outcomes among individuals of African ancestry

LA Parlato, R Welch, IM Ong, J Long, Q Cai… - The American Journal of …, 2023 - Elsevier
Background Vitamin D deficiency is more common among African-ancestry individuals and
may be associated with adverse health outcomes. Vitamin D binding protein (VDBP) …